The economic burden of cancers attributable to metabolic syndrome in Korea

Dongwoo Kim, Seok Jun Yoon, Young Hoon Gong, Young Ae Kim, Hye Young Seo, Jihyun Yoon, A. Rim Kim

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Abstract

Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers' costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.

Original languageEnglish
Pages (from-to)180-187
Number of pages8
JournalJournal of Preventive Medicine and Public Health
Volume48
Issue number4
DOIs
Publication statusPublished - 2015 Jul 1

Keywords

  • Economic burden
  • Metabolic syndrome
  • Neoplasm

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'The economic burden of cancers attributable to metabolic syndrome in Korea'. Together they form a unique fingerprint.

Cite this